Immunology tests and controls CHUL

This tender concerns the provision of immunology tests and controls for the CHUL (Centre hospitalier universitaire de Québec). The procurement falls under categories G21 - Medical and Pharmaceutical Supplies and Equipment, specifically Laboratory Equipment and Immunology Reagents. The contracting authority is CHU de Québec-Université Laval. The procurement method is a negotiated contract (Contrat de gré à gré), justified by Article 14, indicating that the contract value is below the public tender threshold. This suggests a direct negotiation with a selected supplier, likely due to specific product requirements, existing relationships, or the nature of the services. The CHU de Québec-Université Laval requires these tests and controls to support its diagnostic and research activities in immunology. The tender documents will outline the specific types of tests, required reagents, quality standards, and quantities needed. The objective is to ensure the availability of essential diagnostic tools for patient care and medical research within the institution. The negotiated contract approach allows for a streamlined process for acquiring these specialized items, ensuring continuity of service and adherence to the hospital's operational needs. Further details regarding the scope and specifications are available in the full tender documentation.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Laboratory and Medical Equipment. Located in Canada, North America, this opportunity is open to firms and consortiums.

Published through Quebec SEAO, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.